Simcere Pharmaceutical Group Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
21.17 | 35.42 | -40.23% | 25.03 | -15.44% |
| P/S |
|
2.29 | 7.59 | -69.82% |
|
|
| P/BV |
|
2.09 | 3.68 | -43.15% |
|
|
| P/FCF |
|
-20.68 | 55.3 | -137.4% |
|
|
| Ev/Ebitda |
|
13.21 | 2.91 | 354.28% |
|
|
| Ev/S |
|
2.41 | 23.72 | -89.83% |
|
|
| Ev/FCF |
|
-19.22 | 63.78 | -130.14% |
|
|
| E/P |
|
0.0417 | 0.0326 | 27.79% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
6/10
|
19.08 | -11.9 | -260.32% | 26.12 | -26.96% |
| ROE |
|
9.96 | 5.19 | 92.08% |
|
|
| ROA |
|
6.61 | 3.47 | 90.44% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
10.82 | -11.49 | -194.19% |
|
|
| ROCE |
|
0 | 6.04 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
8/10
|
1.25 | 0.7755 | 61.52% | 1.21 | +3.27% |
| Nеt Debt/Ebitda |
|
0 | 0.0127 | -100% |
|
|
| Debt/Ratio |
|
0.1391 | 0.1229 | 13.24% |
|
|
| Debt/Equity |
|
0.7056 | 0.802 | -12.02% |
|
|
| Debt/Net Income |
|
2.11 | 1.76 | 20.2% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
7.9/10
|
3.16 | 2.43 | 30.01% | 3.46 | -8.61% |
| Number of years of dividend growth |
|
0 | 1.21 | -100% | ||
| DSI |
|
0.8 | 0.563 | 42.1% |
|
|
| Average dividend growth |
|
-0.4316 | 3.2 | -113.48% |
|
|
| Average percentage for 5 years |
|
3.46 | 1.82 | 90.48% |
|
|
| Average percentage for payments |
|
73.28 | 23.96 | 205.84% |
|
|
| Difference from average difference in sector |
|
0.7295 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
5/10
|
31.19 | 28.69 | 8.71% | ||
| Growth impulse Ebitda in 5 years |
|
-2.93 | -40.52 | -92.77% | ||
| Growth impulse Net Income in 5 years |
|
-28.78 | 94.84 | -130.35% | ||
| Growth impulse FCF in 5 years |
|
-412.59 | 91.41 | -551.36% | ||
| Growth impulse EPS in 5 years |
|
-36.4 | -118.14 | -69.19% |
IP Score
5/10
